LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares

Bulletin Express

03/04

Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.

The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1163719670"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163719670\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163719670?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 17:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163719670","market":"hk","top_or_hot":-1,"title":"LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares","media":"Bulletin Express","content":"<p>Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.</p>\n<p>The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLUZHU BIOTECH-B (02480) Publishes February 2026 Monthly Return With No Change in Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-04 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.</p>\n<p>The announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02480","symbol_name":"绿竹生物-B","start_time":0,"source_url":"","article_id":"1163719670","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163719670","pubTimestamp":1772615698,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02480":"绿竹生物-B"},"translate_title":"露珠生物-B(02480)公布2026年2月已发行股份无变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02480":1},"content_text":"Beijing Luzhu Biotechnology Co., Ltd. (LUZHU BIOTECH-B, stock code 02480) released its monthly return for the period ended 28 February 2026, showing that the total issued share capital remained constant at 202.45 million shares (par value RMB 1 each). Within this amount, treasury shares stood at 3.54 million, and the number of shares in public circulation remained unchanged.\nThe announcement confirmed that the company continues to meet the 25% minimum public float requirement. During February 2026, there were no new share issues, conversions, or cancellations, and no share options or warrants were outstanding. The filing also noted that the concept of authorized share capital does not apply under the company’s legal structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}